We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Vertex Pharma Acquires ViroChem For $395M

Law360 (March 16, 2009, 12:00 AM EDT) -- In a strategic move meant to strengthen its hepatitis C treatment pipeline, Vertex Pharmaceuticals Inc. has acquired Canada-based ViroChem Pharmaceuticals Inc. for around $395 million, including $100 million in cash....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.